BioCardia
BCDA
25 hedge funds and large institutions have $4.87M invested in BioCardia in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
101% more call options, than puts
Call options by funds: $597K | Put options by funds: $297K
54% more capital invested
Capital invested by funds: $3.17M → $4.87M (+$1.7M)
9% more funds holding
Funds holding: 23 → 25 (+2)
0.26% more ownership
Funds ownership: 0.61% → 0.87% (+0.26%)
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$1.13M |
| 2 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$278K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$22K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$11.5K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$7.42K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
-$53K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$46.3K |
| 3 |
Millennium Management
New York
|
-$19K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$9.47K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.47K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Dimensional Fund Advisors
Austin,
Texas
| – | -$53K | -1,827 | Closed |
|
BCDA Hedge Fund Activity: Q4 2022 in Review
25 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in BioCardia (BCDA) for Q4 2022, worth a combined $4.87M — up 54% from $3.17M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new BCDA positions and 1 closed out — a net gain of 2 holders — while 6 added to existing stakes and 6 trimmed.
The largest buyer was AIGH Capital Management, opening a new position worth an estimated $1.13M. The largest seller was Dimensional Fund Advisors, exiting entirely with an estimated $53K sold.
- 25 institutional investors held BioCardia (BCDA) as of Q4 2022, up from 23 in Q3 2022.
- Funds reported $4.87M of BioCardia stock for Q4 2022, up 54% quarter-over-quarter.
- 3 funds opened new BioCardia positions in Q4 2022 and 1 closed out, a net change of +2 holders.
- The largest BioCardia buyer in Q4 2022 was AIGH Capital Management, an estimated $1.13M added.
- The largest BioCardia seller in Q4 2022 was Dimensional Fund Advisors, an estimated $53K sold.
Based on aggregated 13F filings for Q4 2022.